|
CA3057330A1
|
|
Treating cancer with cas endonuclease complexes
|
|
US2015167096A1
|
|
Compositions and methods for treating cancer
|
|
US2013309667A1
|
|
Primers for analyzing methylated sequences and methods of use thereof
|
|
US2013310550A1
|
|
Primers for analyzing methylated sequences and methods of use thereof
|
|
US2013157875A1
|
|
Methods for assessing genomic instabilities
|
|
US2013109576A1
|
|
Methods for detecting mutations
|
|
US2012309010A1
|
|
Detection of nucleic acids and proteins
|
|
US2013122494A1
|
|
Detection of cancer
|
|
US2012252019A1
|
|
Detection of Bladder Cancers
|
|
US2012252020A1
|
|
Screening Assay for Bladder Cancer
|
|
US2012244536A1
|
|
Detection of Bladder Cancer Recurrence
|
|
US2012064529A1
|
|
Detection of nucleic acids and proteins
|
|
US2011200621A1
|
|
Compositions and methods for treating cancer
|
|
US2009047694A1
|
|
Clinical Intervention Directed Diagnostic Methods
|
|
US2009325153A1
|
|
Analysis of heterogeneous nucleic acid samples
|
